Office hysteroscopy in the diagnosis of Cervical Intra-epithelial Neoplasia.

Not Applicable

• Conditions: Cervix cancer screening; Cancer - Cervical (cervix)

• Registration Number: ACTRN12613000425796
• Lead Sponsor: Minia Maternity University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 140

Inclusion Criteria

1- negative pregnancy test.
2- histopathologically proven SIL.
3- Had a satisfactory colposcopic examination (visualization of the squamocolumnar junction and the entire lesion)

Exclusion Criteria

1-Suspicion or evidence of invasive lesions on Papanicolaou smear, biopsy, or colposcopic examination.
2-Positive pregnancy test.
3-Current pelvic inflammatory disease, cervicitis, or other gynecological infection
4-Poor compliance.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
assessment of the ability of office hysteroscopy for diagnosis of endocervical lesions. The assessment based on visualization of the endocervical abnormalities by office hysteroscopy and after application of 5 % acetic acid to delineate the abnormalities. these finding will be compared to endocervical curettage. [At time of examination, all abnormalities will be recorded and will be compared with the results of endocervical curettage. At the end of the study the overall results of hysteroscopy will be compared with the overall results of endocervical curettage.]

Secondary Outcome Measures

Name	Time	Method
The prevalence of endocervical lesions in patents referred with abnormal cytology and/or abnormal visual inspection of the cervix after application of acetic acid (VIA) testing of the cervix.[At the end of the study. the percentage of histological proven endocervical abnormalities will be calculated.]